| Liver Disease Diagnosis and Treatment | Lifetime | 254 | JP 14 | 99.59 |
| Peroxisome Proliferator-Activated Receptors | Lifetime | 177 | JP 10 | 98.42 |
| Gastroesophageal reflux and treatments | Lifetime | 214 | JP 9 | 98.62 |
| Liver Diseases and Immunity | Lifetime | 138 | JP 5 | 98.70 |
| Diet, Metabolism, and Disease | Lifetime | 318 | JP 7 | 98.30 |
| Gastrointestinal motility and disorders | Lifetime | 199 | JP 4 | 98.35 |
| Gastrointestinal disorders and treatments | Lifetime | 565 | JP 78 | 97.77 |
| Helicobacter pylori-related gastroenterology studies | Lifetime | 750 | JP 91 | 97.64 |
| Liver Disease and Transplantation | Lifetime | 980 | JP 64 | 97.78 |
| Pancreatitis Pathology and Treatment | Lifetime | 775 | JP 106 | 97.01 |
| Inflammatory mediators and NSAID effects | Lifetime | 999 | JP 68 | 95.17 |
| Gastrointestinal Bleeding Diagnosis and Treatment | Lifetime | 366 | JP 44 | 94.79 |
| Congenital gastrointestinal and neural anomalies | Lifetime | 278 | JP 17 | 93.93 |
| Space Satellite Systems and Control | Lifetime | 683 | JP 39 | 92.85 |
| Lipid metabolism and disorders | Lifetime | 865 | JP 53 | 92.20 |
| Intestinal and Peritoneal Adhesions | Lifetime | 812 | JP 15 | 89.37 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 448 | JP 168 | 88.57 |
| Pathogenesis and Treatment of Hiccups | Lifetime | 782 | JP 107 | 53.60 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 46 | JP 3 | 99.73 |
| Liver Diseases and Immunity | 2021-2025 | 21 | JP 1 | 99.13 |
| Gastrointestinal motility and disorders | 2021-2025 | 37 | JP 1 | 97.82 |
| Gastroesophageal reflux and treatments | 2021-2025 | 40 | JP 1 | 97.76 |
| Diet, Metabolism, and Disease | 2021-2025 | 59 | JP 4 | 98.32 |
| Liver Disease and Transplantation | 2021-2025 | 148 | JP 5 | 98.40 |
| Helicobacter pylori-related gastroenterology studies | 2021-2025 | 155 | JP 8 | 95.64 |
| Hepatocellular Carcinoma Treatment and Prognosis | 2021-2025 | 492 | JP 60 | 95.04 |
| Pancreatic and Hepatic Oncology Research | 2021-2025 | 977 | JP 113 | 94.07 |
| Pancreatitis Pathology and Treatment | 2021-2025 | 394 | JP 36 | 92.92 |
| Gallbladder and Bile Duct Disorders | 2021-2025 | 647 | JP 130 | 90.70 |
| Hepatitis C virus research | 2021-2025 | 642 | JP 46 | 90.96 |
| Pediatric Hepatobiliary Diseases and Treatments | 2021-2025 | 536 | JP 95 | 85.91 |
| Congenital gastrointestinal and neural anomalies | 2021-2025 | 120 | JP 3 | 84.94 |
| Gastrointestinal disorders and treatments | 2021-2025 | 891 | JP 151 | 81.23 |
| Alcohol Consumption and Health Effects | 2021-2025 | 598 | JP 15 | 82.36 |
| Peroxisome Proliferator-Activated Receptors | 2021-2025 | 476 | JP 36 | 70.30 |
| Lipid metabolism and disorders | 2021-2025 | 776 | JP 33 | 63.54 |
| Cancer, Stress, Anesthesia, and Immune Response | 2021-2025 | 707 | JP 26 | 62.47 |
| IgG4-Related and Inflammatory Diseases | 2021-2025 | 473 | JP 145 | 57.79 |
